InspireMD Past Earnings Performance

Past criteria checks 0/6

InspireMD's earnings have been declining at an average annual rate of -19.8%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 15.1% per year.

Key information

-19.8%

Earnings growth rate

86.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate15.1%
Return on equity-64.7%
Net Margin-350.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How InspireMD makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:II2 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 246-23179
31 Dec 236-20158
30 Sep 235-19148
30 Jun 235-19138
31 Mar 235-18128
31 Dec 225-18128
30 Sep 226-18127
30 Jun 225-17117
31 Mar 225-16116
31 Dec 214-15105
30 Sep 213-15104
30 Jun 213-1393
31 Mar 212-1293
31 Dec 202-1182
30 Sep 203-982
30 Jun 203-982
31 Mar 204-972
31 Dec 194-1083
30 Sep 194-1073
30 Jun 193-1073
31 Mar 193-872
31 Dec 184-872
30 Sep 184-1171
30 Jun 184-1171
31 Mar 183-1271
31 Dec 173-1381
30 Sep 172-1081
30 Jun 172-1071
31 Mar 172-971
31 Dec 162-861
30 Sep 162-962
30 Jun 162-1172
31 Mar 162-1383
31 Dec 152-16104
30 Sep 153-18114
30 Jun 152-21136
31 Mar 152-24158
31 Dec 143-25169
30 Sep 144-26169
30 Jun 145-23158
31 Mar 146-30157
31 Dec 136-29145
30 Sep 136-26136

Quality Earnings: II2 is currently unprofitable.

Growing Profit Margin: II2 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: II2 is unprofitable, and losses have increased over the past 5 years at a rate of 19.8% per year.

Accelerating Growth: Unable to compare II2's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: II2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).


Return on Equity

High ROE: II2 has a negative Return on Equity (-64.67%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.